667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 137,285 shares at $74.24 ($10.2M) on 2018-11-27, disclosed to the SEC on 2018-11-28.
Open-market sale of $10.2M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.76 | 970 | $72K | 0.7% |
| 2 | $73.76 | 5,627 | $415K | 4.1% |
| 3 | $73.76 | 36,652 | $2.7M | 26.6% |
| 4 | $74.24 | 2,052 | $152K | 1.5% |
| 5 | $74.24 | 77,558 | $5.8M | 56.6% |
| 6 | $74.24 | 11,907 |
| $884K |
| 8.7% |
| 7 | $74.24 | 1,190 | $88K | 0.9% |
| 8 | $74.24 | 1,329 | $99K | 1.0% |
| Total | $74.09 avg | 137,285 | $10.2M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |